S Sangrajrang1, F Calvo, A Fellous
1Laboratoire de Pharmacologie, Institut de Génétique Moléculaire, Hôpital Saint-Louis, Paris, France.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Estramustine (EM), an antimicrotubule drug, shows promise beyond prostate cancer. Drug resistance to EM involves complex cellular adaptations, distinct from multidrug resistance, affecting tubulin and tau expression.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: